Obesity Clinical Trials

• Diagnosis of type 2 diabetes mellitus (T2DM).

• Receiving stable therapy for T2DM for 3 months prior to Screening. This includes diet and/or exercise alone or in combination with any oral medication for T2DM treatment except for DPP-4 inhibitors. Participants can be treatment naïve if they have an HbA1c of 6.5% to 7.5%, inclusive.

• BMI ≥27 kg/m\^2.

• History of being unresponsive to at least 1 self-reported effort to lose weight with diet and/or exercise in the last 6 months.